Cannara Biotech Inc. (LOVFF) Investment Research Dashboard
About Cannara Biotech Inc. (LOVFF) stock analysis
Get live LOVFF stock price $1.35, comprehensive Cannara Biotech Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time LOVFF stock data and investment insights.
Loading chart data...
Cannara Biotech Inc. (LOVFF) Overview
Cannara Biotech Inc. (LOVFF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, LOVFF trades at $1.35 with a market capitalization of 133.36M . Over the past 52 weeks, LOVFF has traded between $1.11 and $1.47 , with the current price positioned at approximately 67% of this range . ...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 133.36M
- Current price: $1.35
- 52-week range: $1.11 - $1.47
- P/E ratio: 16.88
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. ...
Company Information
- CEO
- Zohar Krivorot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 452
Contact Information
- Website
- https://cannara.ca
- Address
- 333 Decarie Blvd. Suite 200
- Country
- CA
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 16.9)
✓ Lower volatility stock (Beta: 0.35) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Cannara Biotech Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Cannara Biotech Inc.
- ⚠Investors should consider how Cannara Biotech Inc. fits within their overall portfolio allocation
Market Cap
133.36M
P/E Ratio (TTM)
16.88
Beta
0.35
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare LOVFF with peer companies:
- Price
- $10.44+0.24% (1D)
- Market cap
- 119.36M
- Price
- $1.79+1,252.27% (1D)
- Market cap
- 182.54M
- Price
- $0.39+0.61% (1D)
- Market cap
- 98.07M
- Price
- $2.98-0.67% (1D)
- Market cap
- 93.20M
- Price
- $0.57+145.26% (1D)
- Market cap
- 265.02M
- Price
- $0.00+0.00% (1D)
- Market cap
- 13.35K
- Price
- $1.55-12.43% (1D)
- Market cap
- 54.45M
- Price
- $1.77+0.00% (1D)
- Market cap
- 62.17M
- Price
- $0.08+0.00% (1D)
- Market cap
- 81.50M
- Price
- $0.00+0.00% (1D)
- Market cap
- 667
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
80/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +5.7% | +6.1% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | +2.9% | +4.3% | 22.2 | 86/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +3.3% | +3.5% | 24.1 | 80/100⭐⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.1% | -0.2% | 25.2 | 56/100⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.7% | +1.2% | 29.7 | 56/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | -0.1% | -1.6% | 29.2 | 43/100⭐⭐⭐ |
| Energy | -2.1% | -5.8% | -5.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | -3.0% | -5.9% | 26.8 | 28/100⭐⭐ |
| Industrials | +0.6% | +1.7% | -11.2% | 30.1 | 26/100⭐⭐ |
| Consumer Cyclical | +0.5% | -0.4% | -6.3% | 43.0 | 21/100⭐ |
| Technology | +0.6% | -2.3% | -9.6% | 40.7 | 17/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.